1.
|
Phase: Phase III, Phase II Type: Behavioral study, Biomarker/Laboratory analysis, Supportive care Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: BRS0008, K07CA132916-01A1, 25740, NCT01011218
|
|
2.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2009-0976, NCT01202851
|
|
3.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: GWCA0999, 2009-016529-32, NCT01337089
|
|
4.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 2009-0517, NCT01219673
|
|
5.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000656564, NCCTG-N07C4, N07C4, NCT00993928
|
|
6.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MMR-117597, NCT01034215
|
|
7.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2009-0854, NCT01375114
|
|
8.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 to 95 Sponsor: Other Protocol IDs: 132500, NCT01530373
|
|
9.
|
Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2012-0117, NCT01746043
|
|
10.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Educational/Counseling/Training, Supportive care Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2004-0024, MDA-CCC-0106, CDR0000357213, NCT00086762
|
|
11.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2004-0598, NCT00505544
|
|
12.
|
Phase: No phase specified Type: Supportive care Status: Active Age: 21 to 65 Sponsor: Other Protocol IDs: 07-0924, 5K23NR010587, NCT00672217
|
|
13.
|
Phase: No phase specified Type: Educational/Counseling/Training, Supportive care Status: Active Age: 18 to 89 Sponsor: Pharmaceutical / Industry Protocol IDs: SMI-CHOL-82008, NCT00737399
|
|
14.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 21 to 81 Sponsor: Other Protocol IDs: HM13194, NCT01411943
|